• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy

by Jasmine Pennic 08/12/2022 Leave a Comment

Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy

What You Should Know: - Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.  - FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More

H1 Launches AI-Powered and Evidence-Based Interactions

by Syed Hamza Sohail 08/11/2022 Leave a Comment

H1 Launches AI-Powered and Evidence-Based Interactions

What You Should Know: - H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams. - New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.  Establishing AI-Driven Efficient Workflows H1 is
Read More

Astellas Pharma Selects Verizon to Transform Global Network

by Jasmine Pennic 08/10/2022 Leave a Comment

Astellas Pharma Selects Verizon to Transform Global Network

What You Should Know: - Verizon Business has announced that it has been selected to build and manage Astellas Pharma Inc’s (Astellas) global network infrastructure.  - Today’s announcement builds on the company’s network-as-a-service foundation and supports its private networks, mobile edge compute and business solutions vectors of growth. The Japanese multinational pharma company, one of the 30 biggest pharmaceutical companies in the world by revenue in 2022, is looking to
Read More

Healthcare Companies on the Stock Market

by HITC Staff 08/10/2022 Leave a Comment

Good healthcare and the financial sector cannot be separated entirely, even when their base motivations lie in different directions. While the medical sector should focus more on the health of the patients instead of consumerism, a good amount of capital is needed to ensure a functional system. Naturally, we can find healthcare companies on the stock market. Considering the continuous need for health care, that is not tied to market crashes the way other stocks are, this is a great chance for
Read More

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

by Syed Hamza Sohail 08/03/2022 Leave a Comment

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

What You Should Know: - H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development - As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.  Integrating Clinical Trial Data Sources to Intelligence Platforms Lokavant is a clinical
Read More

How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement

by Christopher Ianelli, MD, Ph.D., Founder & CEO of iSpecimen 08/02/2022 Leave a Comment

How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement

Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

by Syed Hamza Sohail 07/28/2022 Leave a Comment

NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers

What You Should Know: - NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS). - This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More

Syapse Raises $35M to Expand Learning Health Network

by Jasmine Pennic 07/27/2022 Leave a Comment

Syapse Raises $35M to Expand Learning Health Network

What You Should Know: - Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers. - The investment will allow Syapse to expand its artificial intelligence and machine learning capabilities, making it more efficient to uncover meaningful insights from real-world oncology data.   Syapse, a San Francisco, CA-based real-world evidence company accelerating the
Read More

UCLA Research Uses Saliva to Detect Cancer Biomarkers

by Syed Hamza Sohail 07/27/2022 Leave a Comment

UCLA Health’s COVID-19 Swab Shortage Solved With 3D-Printed Swabs

What You Should Know: - Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva. - Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More

Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video

by Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv 07/26/2022 Leave a Comment

Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video

Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media.    Pharma advertisers spend billions on traditional TV advertising, but as streaming services began to experience explosive growth early in the pandemic, advertising strategies had to adapt. TV-centric advertisers relied on (and still rely on) dayparting (scheduling ads during certain times of the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 52
  • Go to page 53
  • Go to page 54
  • Go to page 55
  • Go to page 56
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |